Cardiogenesis Corporation Reports Delay in Earnings Release and Confe... ( IRVINE Calif. Feb. 29 /- Cardioge...)

Cardiogenesis Corporation Reports Delay in Earnings Release and Conference Call

Date:2/29/2008

IRVINE, Calif., Feb. 29 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products and accessories used in angina-relieving procedures, today announced that it will delay its earnings release and investor conference call for the fourth quarter and full year ended December 31, 2007. The earnings release and investor conference call was previously scheduled for Tuesday, March 4, 2008.

The Company noted that the delay is due to logistical issues and is unrelated to any significant changes in the Company's financial condition, results of operations or in the effectiveness of the Company's internal controls. The Company will issue a subsequent announcement regarding the new date and time of its earnings release and conference call within the next week.

About Cardiogenesis Corporation

Cardiogenesis is a medical device company specializing in the treatment of cardiovascular disease and is a leader in devices that stimulate cardiac angiogenesis. The company's market leading Holmium: YAG laser system and disposable fiber-optic accessories are used to perform a FDA-cleared surgical procedure known as Transmyocardial Revascularization (TMR) to treat patients suffering from angina. Surgical products and accessories for the Cardiogenesis TMR procedure, which are marketed in the U.S. and around the world, have been shown to reduce angina and improve the quality of life in patients with coronary artery disease. Surgical products and accessories for the company's minimally invasive Percutaneous Myocardial Channeling (PMC) procedure are currently being marketed in Europe and other international markets.

For more information on the company and its products, please visit the Cardiogenesis company website at http://www.cardiogenesis.com or the direct to patient website at http://www.heart
'/>"/>

SOURCE Cardiogenesis Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
2. Cardiogenesis Corporation to Report 2007 Fourth Quarter and Year-End Results on March 4th
3. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
4. Brooke Franchise Corporation Announces Selected July Results
5. MedThink Communications Retained by NanoBio Corporation
6. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
7. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
8. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
11. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments

Post Your Comments:

(Date:11/30/2009)...Nov. 30 In Massachusett...ease are cared for at home, so the Alzheimer,s Ass...24/7 Helpline during the holiday season. For most ...or togetherness and sharing, but for a family deal...ul and filled with special challenges, according t...

(Date:11/30/2009)...strator Alonzo L. Fulgham ,, WASHINGTON, Nov. ... global community once again recognizes World AIDS...S worldwide. This is also a time to renew our com...demic and pay homage to the millions of people who...partner in the U.S. President,s Emergency Plan for...

(Date:11/30/2009)...PRNewswire-FirstCall/ - AIM Health Group Inc. ("AI...ted health care company, announced today that its ...ber 30, 2009 (the "Quarter") increased to $633,199...ame time EBITDA(1) increased 290% to $910,734 from...mpany also announced that revenues increased 87% t...

(Date:11/30/2009)... 30 Mary Rita Hyland, Assistant Vi...up, Inc., (SSI) has been elected to the 2010 Board... (WEDI). ,, Hyland has held a variety of leade...ion in 2001. She was initially charged with the de...division and Business Continuity for SSI. She late...

(Date:11/30/2009)...v. 30 A revolutionary new technolo...s, and patients with seamless, real-time access to... of a button was announced today by Candelis, Inc....nagement, visualization and workflow optimization ...y with the cumbersome and costly method of sharing...

Breaking Medicine News(10 mins):Health News:Alzheimer's Caregivers Face Holiday Stress 2 Health News:USAID Recognizes World AIDS Day 2 Health News:AIM Health Group Inc. continues increased quarterly profits 2 Health News:AIM Health Group Inc. continues increased quarterly profits 3 Health News:AIM Health Group Inc. continues increased quarterly profits 4 Health News:SSI Assistant Vice President Elected to WEDI Board 2 Health News:Candelis Announces Revolutionary Cloud-Hosted Data Services 2 Health News:Candelis Announces Revolutionary Cloud-Hosted Data Services 3

[0] Alzheimer's Caregivers Face Holiday Stress [0] USAID Recognizes World AIDS Day [0] AIM Health Group Inc. continues increased quarterly profits [0] SSI Assistant Vice President Elected to WEDI Board [0] Candelis Announces Revolutionary Cloud-Hosted Data Services

...e,which for most Americans means time spent in sto...h family and friends. All of this time spent,indoo...sk for contracting,viruses, particularly influenza...is sometimes deadly virus, but also to help,protec...

...; Adjusted EPS $0.47, CORONA, Calif., Oct. 29 Wa...g specialty pharmaceutical,company, today reported...tember 30, 2008., Third Quarter 2008 Results, Ne...ion, or $0.62 per diluted share. Excluding special...

...nd in early lactation would... Oct. 29 Current methods,for detecting and diagno...eds of dairy producers well, according to a survey...inarians,surveyed are responsible for nearly 2 mil...

...,s ADA Approved, 100%,Recycled EntryLevel(TM) Land...ct. 29 For nearly 40 million,of-voting-age Americ... just,a decision of who to vote for, rather, an is... to determine whether the,nearest polling center c...

...ay that it has been chosen to present at the 2008 ...r 30, 2008 to be held in New York City. , ...-- Curemark announced today that it has been cho...althcare Venture Summit presented by Young Startup...

...n addition to its roster of online degree programs...r 29, 2008 -- Gonzaga University ( www.gonzagaonli...based in Spokane, has announced the addition of a ...onal Leadership and Master of Science in Nursing. ...

Give the Gift of Good Health This Holiday Season - Remind Friends and Family to Get a Flu Shot Watson Pharmaceuticals Reports Third Quarter 2008 Results Dairy Veterinarians Highlight Need for Improved Methods for Detecting Mastitis SafePath(TM) Products Provides Universal Access for Ohio Voters Curemark to Present at the 2008 Life Sciences & Healthcare Venture Summit 2008 Gonzaga Online Updates Communications Masters Program To Meet the Needs of Today's Professionals

(Date:11/30/2009)..., , SAN CARLOS, Calif., Nov. 30 /PRNewsw...TR ) today announced the promotion of Lorianne Mas...cal Officer. Dr. Masuoka will report directly to ...ward W. Robin. ,, "Lorianne,s outstanding lea...strategies have been instrumental in rapidly advan...

(Date:11/30/2009)..., , BOTHELL, Wash., Nov. 30 /PRNewswire... ) announced today that on November 25, 2009, the ...y that it had accepted the Company,s plan to compl... under Section 1003(a)(iv) of the Exchange Company...d that the Company sustained losses which were so ...

(Date:11/30/2009)..., , NEW YORK, Nov. 30 /PRNewswire/ ...search report is available in its catalogue: ,,...lligence Report ,, http://www.reportlinker.co...rket-Intelligence-Report.html ,, Cardiovascul... deaths globally. Sudden cardiac arrest survivors ...

Breaking Medicine Technology:Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2 Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3 SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2 SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3 SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4 Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2 Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3 Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4 Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5 Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6 Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7 Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8 ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 1 ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 2 ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 3 ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 4 ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 5 Study identifies potential fix for damaged knees 51203 1 Study identifies potential fix for damaged knees 51203 2 Study identifies potential fix for damaged knees 51203 3 European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 1 European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 2

[0] Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer [0] SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards [0] Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report

...esults Prompted Phase 2 Study Now Underway at Nine...swire/ -- Ceregene,Inc., a biopharmaceutical comp... a Phase 1 clinical trial of CERE-120, a gene,ther...rkinson,s,disease, demonstrating a 36 percent (p<0...hs after administration, as measured,by the Unifie...

...ass., April 16, 2007 /PRNewswire-FirstCall/ --,Gen...ed study of,Renvela(TM) (sevelamer carbonate) achi...ically significant reduction in serum,phosphorus f...disease who are not on dialysis. , Patients treate...on in calcium-phosphorus product and in LDL choles...

Other Medicine Technology:Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 2 Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 3 Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 4 Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease 2 Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease 3

Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease

Cholesterol-5

Cholesterol Reagent

Omega 12ic

Genegnome Bio Imaging System for Chemiluminescence

Medicine Products:

Cholesterol-5 Cholesterol Reagent Omega 12ic Genegnome Bio Imaging System for Chemiluminescence

Cardiogenesis Corporation Reports Delay in Earnings Release and Confe...( IRVINE Calif. Feb. 29 /- Cardioge...),Health